The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of ...

The correction relates to around three million sensors used in Abbott’s FreeStyle Libre 3 and Libre 3 Plus CGMs in the US.

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some ...

Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...

Abbott Laboratories announced a recall of Freestyle Libre 3 and Libre 3 Plus sensors used in continuous glucose monitors after receiving reports of more than 700 injuries and seven fatalities that may ...

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 18, 2025 / As we observe National Diabetes Month, St. Joseph Medical is ...

According to Precedence Research, the global glucose biosensors market size will grow from USD 10.71 billion in 2025 to nearly USD 23.08 billion by 2034, with an expected CAGR of 8.91% from 2025 to ...

Through teaching, publishing, convening, fact-checking and media literacy, Poynter creates a crossroads where communities come together to use journalism to confront society’s complex problems.

Abstract: In this work, a new technique to characterize a microwave orbital angular momentum (OAM) beam applying a single-sensor compressive imaging (SSCI) strategy is reported, which is much more ...